Imaging manifestations of progressive multifocal leukoencephalopathy

Clinical Radiology

Volumn 65, Issue 6, 2010, Pages 431-439

  Shah, R ^a   Bag, A K ^a   Chapman, P R ^a   Cure J K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM; THALLIUM;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMAGE DISPLAY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; IMMUNOCOMPROMISED PATIENT; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PROCEDURES; UNITED STATES;

DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE SPECTROSCOPY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UNITED STATES;

EID: 77951667069     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2010.03.001     Document Type: Review

References (74)

1. Padgett B.L., Walker D.L., ZuRhein G.M., et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1 (1971) 1257-1260
2. Rosenbloom M.A., and Uphoff D.F. The association of progressive multifocal leukoencephalopathy and sarcoidosis. Chest 83 (1983) 572-575
3. McCormick W.F., Schochet Jr. S.S., Sarles H.E., et al. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med 136 (1976) 829-834
4. Richardson Jr. E.P. Progressive multifocal leukoencephalopathy. N Engl J Med 265 (1961) 815-823
5. Miller J.R., Barrett R.E., Britton C.B., et al. Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med 307 (1982) 1436-1438
6. Calabrese L.H., and Molloy E.S. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 67 Suppl. 3 (2008) iii64-iii65
7. Focosi D., Maggi F., Ceccherini-Nelli L., et al. Progressive multifocal leukoencephalopathy in autoimmune disorders. Gut 58 (2009) 605
8. Berger J.R. Natalizumab. Drugs Today (Barc) 42 (2006) 639-655
9. Freim Wahl S.G., Folvik M.R., and Torp S.H. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 26 (2007) 68-73
10. Bonavita S., Conforti R., Russo A., et al. Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. Neurol Sci 29 (2008) 37-39
11. Calabrese L.H., and Molloy E.S. Therapy: rituximab and PML risk-informed decisions needed!. Nat Rev Rheumatol 5 (2009) 528-529
12. Piccinni C., Sacripanti C., Poluzzi E., et al. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. Eur J Clin Pharmacol 66 (2010) 199-206
13. Koralnik I.J., Schellingerhout D., and Frosch M.P. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. N Engl J Med 350 (2004) 1882-1893
14. d'Arminio Monforte A., Cinque P., Mocroft A., et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 55 (2004) 320-328
15. Antinori A., Cingolani A., Lorenzini P., et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9 Suppl. 1 (2003) 47-53
16. Viallard J.F., Lazaro E., Lafon M.E., et al. Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 46 (2005) 1659-1662
17. Herrlinger U., Schwarzler F., Beck R., et al. Progressive multifocal leukoencephalopathy: cidofovir therapy in three patients with underlying hematological disease. J Neurol 250 (2003) 612-614
18. Vollmer-Haase J., Young P., and Ringelstein E.B. Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 349 (1997) 1366
19. Wenning W., Haghikia A., Laubenberger J., et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361 (2009) 1075-1080
20. Gheuens S., Pierone G., Peeters P., et al. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81 (2010) 247-254
21. Berger J.R., Pall L., Lanska D., et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4 (1998) 59-68
22. Weber T., Turner R.W., Frye S., et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 169 (1994) 1138-1141
23. Fong I.W., Britton C.B., Luinstra K.E., et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol. 33 (1995) 484-486
24. McGuire D., Barhite S., Hollander H., et al. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37 (1995) 395-399
25. Antinori A., Ammassari A., De Luca A., et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48 (1997) 687-694
26. Bag A.K., Curó J.K., Chapman P.R., Roberson G.H., and Shah R. JC virus infection of brain. [Published online ahead of print Mar 18, 2010]. AJNR Am J Neuroradiol (2010). http://www.ajnr.org/pap.dtl http://www.ajnr.org/pap.dtl. Accessed Mar 26, 2010.
27. Marzocchetti A., Di Giambenedetto S., Cingolani A., et al. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol. 43 (2005) 4175-4177
28. Glass A.J., and Venter M. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa. J Med Virol 81 (2009) 1929-1937
29. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin 26 (2008) 833-854 x-xi
30. Carroll B.A., Lane B., Norman D., et al. Diagnosis of progressive multifocal leukoencephalopathy by computed tomography. Radiology 122 (1977) 137-141
31. Krupp L.B., Lipton R.B., Swerdlow M.L., et al. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 17 (1985) 344-349
32. Trotot P.M., Vazeux R., Yamashita H.K., et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. Pathological correlations. J Neuroradiol 17 (1990) 233-254
33. Guilleux M.H., Steiner R.E., and Young I.R. MR imaging in progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 7 (1986) 1033-1035
34. Post M.J., Yiannoutsos C., Simpson D., et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol 20 (1999) 1896-1906
35. Whiteman M.L., Post M.J., Berger J.R., et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187 (1993) 233-240
36. Kastrup O., Maschke M., Diener H.C., et al. Progressive multifocal leukoencephalopathy limited to the brain stem. Neuroradiology 44 (2002) 227-229
37. Mathew R.M., and Murnane M. MRI in PML: bilateral medullary lesions. Neurology 63 (2004) 2380
38. Svensson P.A., and Larsson E.M. Infratentorial progressive multifocal leucoencephalopathy (PML) in a patient with SLE (2008: 4b). Eur Radiol 18 (2008) 1526-1528
39. Semmler A., Urbach H., Klockgether T., et al. Progressive multifocal leukoencephalopathy with selective involvement of the pyramidal tracts. Neurology 68 (2007) 871
40. Sobha N., Sinha S., Taly A.B., et al. Progressive multifocal leucoencephalopathy with discrete involvement of pyramidal tract. J Neurol Neurosurg Psychiatry 76 (2005) 24
41. Boster A., Hreha S., Berger J.R., et al. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol 66 (2009) 593-599
42. Mark A.S., and Atlas S.W. Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 173 (1989) 517-520
43. Sarrazin J.L., Soulie D., Derosier C., et al. MRI aspects of progressive multifocal leukoencephalopathy. J Neuroradiol 22 (1995) 172-179
44. Thurnher M.M., Post M.J., Rieger A., et al. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 22 (2001) 977-984
45. Kuker W., Mader I., Nagele T., et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol 13 (2006) 819-826
46. Smith A.B., Smirniotopoulos J.G., and Rushing E.J. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. RadioGraphics 28 (2008) 2033-2058
47. Post M.J., Tate L.G., Quencer R.M., et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol 151 (1988) 373-380
48. Yousry T.A., Major E.O., Ryschkewitsch C., et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354 (2006) 924-933
49. Takeda S., Yamazaki K., Miyakawa T., et al. Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology 29 (2009) 485-493
50. Bernal-Cano F., Joseph J.T., and Koralnik I.J. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol 13 (2007) 474-476
51. da Pozzo S., Manara R., Tonello S., et al. Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up. Radiol Med 111 (2006) 971-977
52. Bergui M., Bradac G.B., Oguz K.K., et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 46 (2004) 22-25
53. Usiskin S.I., Bainbridge A., Miller R.F., et al. Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR Am J Neuroradiol 28 (2007) 285-286
54. Mukherjee P., Berman J.I., Chung S.W., et al. Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol 29 (2008) 632-641
55. Huisman T.A., Boltshauser E., Martin E., et al. Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination?. AJNR Am J Neuroradiol 26 (2005) 2153-2156
56. Chang L., Ernst T., Tornatore C., et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48 (1997) 836-845
57. Iranzo A., Moreno A., Pujol J., et al. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J Neurol Neurosurg Psychiatry 66 (1999) 520-523
58. Yoon J.H., Bang O.Y., and Kim H.S. Progressive multifocal leukoencephalopathy in AIDS: proton MR spectroscopy patterns of asynchronous lesions confirmed by serial diffusion-weighted imaging and apparent diffusion coefficient mapping. J Clin Neurol 3 (2007) 200-203
59. Simone I.L., Federico F., Tortorella C., et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64 (1998) 516-523
60. Ernst T., Chang L., Witt M., et al. Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging. Radiology 210 (1999) 539-543
61. Iranzo A., Marti-Fabregas J., Domingo P., et al. Absence of thallium-201 brain uptake in progressive multifocal leukoencephalopathy in AIDS patients. Acta Neurol Scand 100 (1999) 102-105
62. Lee V.W., Antonacci V., Tilak S., et al. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 211 (1999) 507-512
63. O'Doherty M.J., Barrington S.F., Campbell M., et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38 (1997) 1575-1583
64. Garrels K., Kucharczyk W., Wortzman G., et al. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 17 (1996) 597-600
65. Sakai M., Inoue Y., Aoki S., et al. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy. Jpn J Radiol 27 (2009) 69-77
66. Gray F., Bazille C., Adle-Biassette H., et al. Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 11 Suppl. 3 (2005) 16-22
67. Tan K., Roda R., Ostrow L., et al. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72 (2009) 1458-1464
68. Falco V., Olmo M., del Saz S.V., et al. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr 49 (2008) 26-31
69. De Luca A., Ammassari A., Pezzotti P., et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22 (2008) 1759-1767
70. Marzocchetti A., Tompkins T., Clifford D.B., et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73 (2009) 1551-1558
71. Berger J.R., Levy R.M., Flomenhoft D., et al. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44 (1998) 341-349
72. McCombe J.A., Auer R.N., Maingat F.G., et al. Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS: outcome and epidemiology. Neurology 72 (2009) 835-841
73. Mader I., Herrlinger U., Klose U., et al. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology 45 (2003) 717-721
74. Cosottini M., Tavarelli C., Del Bono L., et al. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol 18 (2008) 1024-1030